False negative anti-HIV-1 HIV-2 ELISAs in acute HIV-2 infection

被引:16
|
作者
Christiansen, CB [1 ]
Jessen, TE [1 ]
Nielsen, C [1 ]
StaunOlsen, P [1 ]
机构
[1] HOLBAEK CENTRALSYGEHUS,DEPT CLIN CHEM,COPENHAGEN,DENMARK
关键词
D O I
10.1111/j.1423-0410.1996.tb01312.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since HIV-2 was isolated in 1986, only 1 case of acute HIV-2 infection has been reported. We have identified another patient with primary HIV-2 infection, Follow-up samples were requested from the patient due to discrepant results, The HIV-2 infection was confirmed with HIV-2-specific proviral DNA amplification by PCR. The HIV-2 seroconversion panel obtained was used to evaluate the sensitivity of both combined and specific ELISAs currently in use in Europe, and to investigate the Western-blot patterns on both HIV-1- and HIV-2-specific Western blots. The window period was determined to be less than 37 days with the most sensitive assays. A remarkable difference in sensitivity to HIV-2 antibodies in acute HIV-2 infection was found in combined HIV-1/HIV-2 ELISAs. Three out of the 4 combined sandwich ELISAs appeared to be less sensitive than the indirect ELISAs in HIV-2 seroconversion, leading to a prolonged window period. One HIV-2-specific ELISA was also negative on the first sample, but positive on the second sample. In the HIV-2 Western blot, early reaction with HIV-2-specific env and gag proteins was seen, whereas the HIV-1 Western blot on the first sample revealed gag (p24, p55) reactivity only.
引用
收藏
页码:144 / 147
页数:4
相关论文
共 50 条
  • [21] HIV-1 AND HIV-2 DOUBLE INFECTION IN GREECE
    GEORGOULIAS, V
    FOUNTOULI, D
    KARVELAAGELAKIS, A
    KOMIS, G
    MALLIARAKISPINETIDOU, E
    ANTONIADIS, G
    SAMAKIDIS, K
    KONDAKIS, X
    PAPAPETROPOULOU, M
    ZOUMBOS, N
    AXENIDOU, O
    MAKRIS, K
    SONIDIS, G
    ANNALS OF INTERNAL MEDICINE, 1988, 108 (01) : 155 - 155
  • [22] Protection from HIV-1 infection by HIV-2
    Travers, KU
    Eisen, GE
    Marlink, RG
    Essex, ME
    Hsieh, CC
    Mboup, S
    Kanki, PJ
    AIDS, 1998, 12 (02) : 224 - 225
  • [23] TRENDS IN HIV-1 AND HIV-2 INFECTION IN THE GAMBIA
    WILKINS, A
    OELMAN, B
    PEPIN, J
    CHAM, K
    CORRAH, T
    HUGHES, A
    MANNEH, K
    NJAI, R
    ROLFE, M
    SABALLY, S
    WHITTLE, H
    AIDS, 1991, 5 (12) : 1529 - 1530
  • [24] AS FOR HIV-2
    MARWICK, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (09): : 1291 - 1291
  • [25] HIV-2 infection and chemokine receptors usage - Clues to reduced virulence of HIV-2
    Azevedo-Pereira, JM
    Santos-Costa, Q
    Moniz-Pereira, J
    CURRENT HIV RESEARCH, 2005, 3 (01) : 3 - 16
  • [26] SEROPOSITIVITY TO HIV-1 AND HIV-2
    HAYES, RJ
    SMITH, PG
    LANCET, 1987, 1 (8543): : 1199 - 1200
  • [27] EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC
    DECOCK, KM
    ADJORLOLO, G
    EKPINI, E
    SIBAILLY, T
    KOUADIO, J
    MARAN, M
    BRATTEGAARD, K
    VETTER, KM
    DOORLY, R
    GAYLE, HD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (17): : 2083 - 2086
  • [28] Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals: Implications for starting HAART
    Schutten, M
    van der Ende, ME
    Tenner-Racz, K
    Racz, P
    Niesters, HGM
    Osterhaus, ADME
    AIDS, 2000, 14 : S3 - S3
  • [29] HIV-2 infection and HIV-associated nephropathy
    Izzedine, H
    Damond, F
    Brocherio, I
    Ghosn, L
    Lassal, H
    Deray, G
    AIDS, 2006, 20 (06) : 949 - 950
  • [30] HIV-1 AND HIV-2 IN SPAIN
    SAVALL, R
    BALANZO, X
    FERNANDEZ, JL
    VALLS, F
    SORIANO, V
    GENITOURINARY MEDICINE, 1992, 68 (02): : 143 - 143